Sign up to save your podcasts
Or
Share Personalizing the Treatment of Recurrent/Metastatic HNSCC: A Multifactorial Path
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Personalizing the Treatment of Recurrent/Metastatic HNSCC: A Multifactorial Path
CME credits: 0.25
Valid until: 28-02-2024
Claim your CME credit at https://reachmd.com/programs/cme/personalizing-the-treatment-of-recurrentmetastatic-hnscc-a-multifactorial-path/14953/
KEYNOTE-048 has opened new vistas to managing patients with recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC). Nonetheless, uncertainties remain in matching the correct patient with the correct strategy. Join Drs. Barbara Burtness and Nabil Saba as they parse the key trials and offer insight into building treatment algorithms designed to optimize outcomes for your patients with R/M HNSCC.
=
View all episodes
By ReachMD
4.3
33 ratings
CME credits: 0.25
Valid until: 28-02-2024
Claim your CME credit at https://reachmd.com/programs/cme/personalizing-the-treatment-of-recurrentmetastatic-hnscc-a-multifactorial-path/14953/
KEYNOTE-048 has opened new vistas to managing patients with recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC). Nonetheless, uncertainties remain in matching the correct patient with the correct strategy. Join Drs. Barbara Burtness and Nabil Saba as they parse the key trials and offer insight into building treatment algorithms designed to optimize outcomes for your patients with R/M HNSCC.
=